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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S378vibratory sense were each associated with the risk of incident knee
instability, and impaired vibratory sense predicted worsening of both
outcomes (see Table).
Conclusions: In this large cohort of participants, impaired vibratory
sense and quadriceps weakness were each associated with a range of
knee instability outcomes. Thus, vibratory sense and muscle strength
may be important risk factors for knee instability in persons with or at
risk for knee OA.Table.
Adjusted RR (95%CI)** p value Adjusted RR (95%CI)** p value
Knee instability (buckling and/or slipping) incidence Buckling incidence
Vibratory sense at tibial tuberosity Lower 1.21 (0.98, 1.50) 0.084 Lower 1.05 (0.79, 1.40) 0.725
Reference 1 Reference 1
Greater 0.80 (0.57, 1.12) 0.194 Greater 0.68 (0.47, 1.00) 0.049
p for trend 0.024 p for trend 0.213
Quadriceps muscle strength Lower 1.14 (0.92, 1.41) 0.224 Lower 1.33 (1.03, 1.73) 0.030
Reference 1 0.90 (0.64, 1.26) Reference 1
Greater 0.60 (0.44, 0.84) 0.003 Greater 0.90 (0.64, 1.26) 0.537
p for trend <0.001 p for trend 0.028
Worsening knee instability (buckling and/or slipping) Worsening Buckling
Vibratory sense at tibial tuberosity Lower 1.29 (0.87, 1.93) 0.210 Lower 1.00 (0.77, 1.29) 0.979
Reference 1 Reference 1
Greater 0.42 (0.20, 0.88) 0.021 Greater 0.67 (0.47, 0.94) 0.020
p for trend 0.021 p for trend 0.020
Quadriceps muscle strength Lower 1.13 (0.73, 1.75) 0.573 Lower 1.18 (0.93, 1.51) 0.175
Reference 1 Reference 1
Greater 0.76 (0.43, 1.37) 0.363 Greater 0.89 (0.65, 1.22) 0.474
p for trend 0.189 p for trend 0.071
**adjusted for all covariates.670
END-STAGE KNEE OSTEOARTHRITIS IS INDEPENDENTLY ASSOCIATED
WITH A HIGHER PREVALENCE OF MEDICAL COMORBIDITIES
MARKED BY SYSTEMIC INFLAMMATION WHEN COMPARED TO
END-STAGE HIP OSTEOARTHRITIS
M.G. Zywiel, A.V. Perruccio, T. Jackson, R. Gandhi , Arthritis Program,
University Health Network; Univ. of Toronto, Toronto, ON, Canada
Purpose: Osteoarthritis (OA) of the knee has been reported to be
associated with a distinct pathogenesis and clinical proﬁle when com-
pared to OA of the hip. Furthermore, some authors have postulated that
knee OA in particular is marked by low-grade systemic inﬂammation.
However, it is unclear whether this is additionally associated with dif-
ferences in the prevalence of other medical comorbidities that have
been reported to be associated with a low-grade systemic inﬂammatory
state. Thus, the purpose of the present study was to assess whether
individuals with end-stage knee OA are more likely to have medical
comorbidities marked by systemic inﬂammation as compared to those
with end-stage hip OA.
Methods: All patients who underwent primary total knee (TKA) or hip
arthroplasty (THA) for a diagnosis of OAwere extracted from the 2010 to
2012 American College of Surgeons National Surgical Quality
Improvement Project databases. Combined, these databases include
preoperative risk factor and 30 day postoperative morbidity data from
374 clinical sites in North America, abstracted by trained reviewers. The
study cohort encompassed 54,022 cases, including 33,906 of knee OA
and 20,116 of hip OA. Patient data extracted included age, gender, and
body mass index (BMI) stratiﬁed by World Health Organization (WHO)
class. Comorbidities evaluated included hypertension requiring medi-
cation, diabetes, and metabolic syndrome (deﬁned as BMI of 30 kg/m2
or greater as well as the presence of hypertension and diabetes).
Additionally, smoking status within one year of surgery and chronic
systemic steroid use within 30 days of surgery were abstracted.
Descriptive statistics were obtained. Bivariate analyses were performed
using the chi-square statistic for categorical variables, and the Student’s
t-test for continuous variables. Logistic regression analysis was per-
formed to determine whether the odds of the presence of the comor-
bidities of interest differed between the knee and hip groups, adjusted
for covariates.
Results: Knee OA patients were signiﬁcantly older (mean age 67.1 vs
65.7 years; p < 0.001), had a higher prevalence of obesity (61.4% vs
44.6%; p < 0.001), and encompassed a greater proportion of women(62.7% vs 56.4%; p < 0.001) compared to hip OA patients. A signiﬁcantly
greater proportion of knee OA patients were being treated for hyper-
tension (66.8% vs 58.2%; p < 0.001), had diabetes (17.7% vs 8.8%; p <
0.001), and met criteria for metabolic syndrome (3.5% vs 1.7%; p <
0.001). Controlling for age, gender, class of obesity, smoking, and
chronic systemic steroid use, knee OA patients had signiﬁcantly greater
odds of a diagnosis of hypertension (OR 1.11; 95% CI [1.06–1.16]) and
diabetes (OR 1.35; 95% CI [1.27–1.42]), and of meeting the criteria for
metabolic syndrome (OR 1.35; 95% CI [1.18–1.54]).Conclusions: While arthroplasty patients with knee OA are marked by
differences in demographic proﬁle compared to those with hip OA, the
results of the present study demonstrate that these variations alone fail
to explain observed discrepancies in the prevalence of associated
patient comorbidities. Even when controlled for demographic proﬁle,
smoking, and chronic steroid use, patients with knee OA continued to
have signiﬁcantly greater odds of an associated diagnosis of hyper-
tension, diabetes, or the presence of metabolic syndrome. These ﬁnd-
ings further support the notion that knee OA is marked by unique
associations with systemic disease. Further work is needed to better
understand the nature of these associations, as well as to investigate
potential interactions between these conditions, each of which has
been reported to be independently associated with a systemic inﬂam-
matory state.
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OSTEOARTHRITIS-RELATED DISABILITY AND RISK FOR SERIOUS
DIABETES COMPLICATIONS IN PEOPLE WITH DIABETES: A
POPULATION BASED COHORT STUDY
G.A. Hawker y,z, R. Croxford x, A.S. Bierman y, P. Harvey y,z, B. Ravi y,
I. Stanaitis z, L.L. Lipscombe y,z. yUniv. of Toronto, Toronto, ON, Canada;
zWomen’s Coll. Hosp., Toronto, ON, Canada; x Inst. for Clinical Evaluative
Sci. (ICES), Toronto, ON, Canada
Purpose: Functional limitations from hand, hip and knee osteoarthritis
(OA) may impact the ability of diabetes patients to manage their dia-
betes. Thus, we examined the impact of OA symptom severity on dia-
betes-related complications in persons affected by both OA and
diabetes.
Methods: This retrospective cohort study used data from a population
cohort with symptomatic hip and knee OA that was recruited from
1996–98 through a screening survey of 100% of the population aged
55þ years in two Ontario regions (n ¼ 2,225 had OA conﬁrmed on
examination and x-ray). The baseline survey assessed: socio-demo-
graphics; smoking; self-reported height, weight and NSAID use;
comorbidity (including physician diagnosis and treatment in the past
year for high blood pressure, diabetes, and heart problems); and mental
health status (SF-36 mental health subscale). OA functional limitations
were assessed using the Western Ontario McMaster Universities OA
Index, WOMAC, physical function subscale, and the Health Assessment
Questionnaire grip subscale and walking subscale (both 0–3; higher
